Genus plc (LON:GNS – Get Free Report) shares rose 2.2% on Wednesday. The stock traded as high as GBX 2,406 and last traded at GBX 2,390. Approximately 178,452 shares were traded during mid-day trading, a decline of 75% from the average daily volume of 724,650 shares. The stock had previously closed at GBX 2,338.
Analyst Ratings Changes
Separately, Berenberg Bank restated a “buy” rating and issued a GBX 3,350 price objective on shares of Genus in a research report on Tuesday, October 13th. Three analysts have rated the stock with a Buy rating. According to data from MarketBeat, Genus has a consensus rating of “Buy” and a consensus target price of GBX 3,216.67.
Read Our Latest Research Report on GNS
Genus Price Performance
The company has a 50 day simple moving average of GBX 2,244.47 and a 200-day simple moving average of GBX 2,411.70. The stock has a market cap of £1.54 billion, a price-to-earnings ratio of 5.62, a P/E/G ratio of 2.87 and a beta of 0.91. The company has a current ratio of 2.22, a quick ratio of 1.08 and a debt-to-equity ratio of 14.02.
Genus (LON:GNS – Get Free Report) last announced its quarterly earnings data on Thursday, September 10th. The company reported GBX 110.30 earnings per share for the quarter. Genus had a return on equity of 44.90% and a net margin of 43.35%. Research analysts expect that Genus plc will post 70.96 EPS for the current year.
Genus announced that its board has authorized a share repurchase plan on Thursday, September 10th that allows the company to buy back £60 million in outstanding shares. This repurchase authorization allows the company to buy up to 3.9% of its stock through open market purchases. Stock repurchase plans are often a sign that the company’s leadership believes its stock is undervalued.
Insiders Place Their Bets
In other news, insider Jorgen Kokke sold 50,236 shares of the company’s stock in a transaction that occurred on Monday, September 14th. The stock was sold at an average price of GBX 2,151, for a total value of £1,080,576.36. 0.78% of the stock is currently owned by corporate insiders.
Genus Company Profile
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands.
Further Reading
- Five stocks we like better than Genus
- Keeping AI Cool: AAON Rides the AI Heatwave to Record Growth
- AST SpaceMobile Has a New Rocket Plan, But Its Cash-Burn Problem Isn’t Going Away
- Powering Up the Moon: Redwire’s $40 Million NASA Award
- Can Constellation Energy’s Contracts Power a Stock Rebound?
Receive News & Ratings for Genus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus and related companies with MarketBeat.com's FREE daily email newsletter.
